At the same time as researchers seek for biomarkers to forecast ketamine reaction, clinicians find themselves with a conundrum: Which patients really should start with IV ketamine, and which with Spravato? And just how do The 2 compare head to head in actual response to treatment? Besides the chronic treatment https://cordellc333xma1.angelinsblog.com/profile